{"schema_version":"secwatch.filing_event.v1","accession":"0001689375-25-000049","form_type":"8-K","ticker":"TRDA","cik":"0001689375","company_name":"Entrada Therapeutics, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.150126+00:00","generated_at":"2026-05-16T23:47:28.921061+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Entrada Q3 net loss widens to $44.1M; DMD pipeline on track for data in 2026","bullets":["Net loss of $44.1M for Q3 2025, compared to $14.0M net loss in Q3 2024; collaboration revenue fell to $1.6M from $19.6M.","Cash, cash equivalents & marketable securities of $326.8M extended runway into Q3 2027.","ELEVATE-44-201 cohort 1 data on track for Q2 2026; first patient dosed in ELEVATE-45-201 with cohort 1 data expected mid-2026.","Filed UK regulatory authorization for ENTR-601-50; plans to submit EU applications in H2 2026.","Vertex VX-670 (DM1) trial enrollment and dosing on track for completion in H1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001689375-25-000049","json":"https://secwatch.observer/filing/0001689375-25-000049.json","markdown":"https://secwatch.observer/filing/0001689375-25-000049.md","text":"https://secwatch.observer/filing/0001689375-25-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689375/000168937525000049/0001689375-25-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689375/000168937525000049/trda-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:47:28.921061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}